Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Alaunos Therapeutics Inc (TCRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	12-2014	12-2013	12-2012	12-2011
Assets
Current Assets
Cash & Cash Equivalents	140,717	42,803	68,204	73,306	104,713
Receivables	446	145	145	58	79
TOTAL	$152,521	$44,087	$70,297	$80,276	$106,105

Non-Current Assets
PPE Net	581	531	801	1,994	1,141
Other Non-Current Assets	622	619	656	1,134	862
TOTAL	$1,203	$1,150	$1,457	$3,128	$2,003

Total Assets	$153,724	$45,237	$71,754	$83,404	$108,108

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	2,008	2,004	422	1,509	1,727
Accrued Expenses	8,906	7,182	6,357	16,516	10,821
TOTAL	$18,123	$10,826	$7,791	$18,864	$13,363

Non-Current Liabilities
Deferred Revenues	7,209	1,640	1,012	839	815
Other Non-Current Liabilities	0	0	11,796	12,962	19,425
TOTAL	$48,230	$570	$14,580	$16,095	$23,138

Total Liabilities	$66,353	$11,396	$22,371	$34,959	$36,501

Shareholders' Equity
Shares Outstanding, K	879	765	671	558	530
Common Shares	132	104	100	83	69
Retained earnings	-492,700	-372,612	-340,831	-283,724	-187,592
TOTAL	$87,371	$33,841	$49,383	$48,445	$71,607

Total Liabilities And Equity	$153,724	$45,237	$71,754	$83,404	$108,108